FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma
Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis
pharmaceutical investing FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher
Fathom Nickel Announces Filing of NI 43-101 Technical Report for Previously Announced Maiden Mineral Resource Estimate, Gochager Lake Ni-Cu-Co Deposit, Saskatchewan
CoTec Holdings Corp. Notes HyproMag USA Secures Power and Advances Project Readiness for Texas Rare Earth Magnet Recycling and Manufacturing Hub
Renforth Extends Surface Gold Mineralization In Channels On Wholly Owned Parbec Gold Deposit In Malartic, Quebec
